References
- World Health Organization. The World Health Report 2008. Primary Health Care - now more than ever. New York: The World Health Organization. 2008. ISBN 978 92 4 156373 4.
- Barnett K, Mercer SW, Norbury M, et al. Epidemiology of multimorbidity and implications for healthcare, research, and medical education: a cross sectional study. Lancet. 2012;380:37–43.
- Ornstein SM, Nietert PJ, Jenkins RG, et al. The prevalence of chronic diseases and multimorbidity in primary care practice: a PPRNet report. J Am Board Fam Pract. 2013;26:518–524.
- Köberlein J, Jürges H. Multimorbidity, incentives and the use of health services in Europe. Active Ageing and Solidarity between Generations in Europe: First Results from SHARE after the Economic Crisis. 2013;25:243.
- Boyd C, Martin Fortin MD. Future of multimorbidity research: how should understanding of multimorbidity inform health system designs? Public Health Rev. 2010;32:451–474.
- Van Den Bussche H, Schön G, Kolonko T, et al. Patterns of ambulatory medical care utilisation in elderly patients with special reference to chronic diseases and multimorbidity – results from a claims data based observational study in Germany. BMC Geriatr. 2011;11:54.
- World Health Organisation. Definition of an older and elderly person, 2015-last update. [cited 2016 Oct]. Available from http://www.who.int/healthinfo/survey/ageingdefnolder/en/
- Guthrie B, Payne K, Alderson P, et al. Adapting clinical guidelines to take account of multimorbidity. Bmj. 2012;345:e6341.
- Payne RA, Avery AJ, Duerden M, et al. Prevalence of polypharmacy in a Scottish primary care population. Eur J Clin Pharm. 2014;7:575–581.
- Dwyer LL, Han B, Woodwell DA, et al. Polypharmacy in nursing home residents in the United States: results of the 2004 National Nursing Home Survey. The American J Geriatr Pharmac. 2010;8:63–72.
- Ed K, Cd R, Js H, et al. Trends in prescription drug use among adults in the United States from 1999-2012. Jama. 2015;314:1818–1830.
- Payne RA, Avery AJ. Polypharmacy: one of the greatest prescribing challenges in general practice. Brit J Gen Prac. 2011;61:83–84.
- Rollason V, Vogt N. Reduction of polypharmacy in the elderly. A systematic review of the role of the pharmacist. Drugs Aging. 2003;20:817–832.
- Patterson SM, Hughes C, Kerse N, et al. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev. 2012;5.
- Patterson SM, Cadogan CA, Kerse N, et al. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev. 2014;10.
- Cooper JA, Cadogan CA, Patterson SM, et al. Interventions to improve the appropriate use of polypharmacy in older people: a Cochrane systematic review. BMJ Open. 2015;5:e009235.
- Kaufmann CP, Tremp R, Hersberger KE, et al. Inappropriate prescribing: a systematic overview of published assessment tools. Eur J Clin Pharmacol. 2014;70:1–11.
- Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003;163:2716–2724.
- Gallagher P, Ryan C, Byrne S, et al. STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther. 2008;46:72–83.
- Laroche ML, Charmes JP, Merle L. Potentially inappropriate medications in the elderly: a French consensus panel list. Eur J Clin Pharmacol. 2007;63(8):725–731.
- SIMPATHY. Available from. [cited 2016 Oct]. http://www.simpathy.eu/
- Yüksel I. Developing a multi-criteria decision making model for PESTEL analysis. Ijbm. 2012;7:52.
- Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1.
- Brouwers M, Kho ME, Browman GP, et al. AGREE II: advancing guideline development, reporting and evaluation in healthcare. Can Med Assoc J. 2010;182:E839–42.
- Agency for Healthcare Research and Quality National Guideline Clearinghouse. cited 2016 Oct]. Available from https://guideline.gov/
- Guidelines International Network. [cited 2016 Oct]. Available from http://www.g-i-n.net/
- Regionala läkemedelsrådet i Uppsala-Örebroregionen. Behandlingsrekommendationer 2015. Läkemedelsbehandling av de mest sjuka äldre. Version 1.2. [Updated 2015 Mar; cited 2016 Oct]. Available from http://www.kollpalakemedel.se/wp-content/uploads/2015/03/Aldre-mest-sjuka-Behandlingsrekommendationer-2015.pdf
- Scottish Government Model of Care Polypharmacy Working Group. Polypharmacy Guidance. 2nd ed. Edinburgh: Scottish Government; 2015. [cited 2016 Oct]. Available from http://www.sign.ac.uk/pdf/polypharmacy_guidance.pdf
- Västerbottens läns landsting. Terapirekommendationer, 2015. [Cited 2016 Oct]. Available from http://www.vll.se/Sve/Centralt/Standardsidor/V%c3%a5rdOchH%c3%a4lsa/L%c3%a4kemedelscentrum/Nedladdningsboxar/Filer/Terapirekommendationer%202015.pdf
- Västra Götalandsregion. Äldre och läkemedel, 2015. [Cited 2016 Oct]. Available from https://reklistan.vgregion.se/#/advice/Aldre_och_lakemedel
- Bergert FW, Braun M, Ehrenthal K, et al. Recommendations for treating adult and geriatric patients on multimedication. Int J Clin Pharmacol Ther. 2014;52:1–64.
- Corrine Z. Rational drug use. Medication management in the complex chronic patient: reconciliation, revision, deprescription and adherence, 2014. [Cited 2016 Oct]. Available from http://salutweb.gencat.cat/web/.content/home/ambits_tematics/linies_dactuacio/model_assistencial/atencio_al_malalt_cronic/documents/arxius/rational_useCAT2014.pdf
- Schubert I, Hessen HL, DEGAM. Hausärztliche Leitlinie „Multimedikation“, 2014. [Cited 2016 Oct]. Available from http://www.pmvforschungsgruppe.de/pdf/03_publikationen/multimedikation_ll.pdf
- Midlöv P, Kragh A. Chapter: Läkemedelsbehandling hos äldre. In: Läkemedelsboken. Uppsala: Läkemedelsverket; Central Hospital in Kristianstad. 2014. [Cited 2016 Oct]. Available from http://lakemedelsboken.se/pdf/filer/y1_lma_lakemedaldre_2013fm10.pdf
- Verenso. Handreiking Geriatrisch assessment door de specialist ouderengeneeskunde. Utrecht: Verenso; 2014. [Cited 2016 Oct]. Available from http://www.verenso.nl/assets/Uploads/Downloads/Handreikingen/VER-003-29-handrGeriatrischAssesement-v4.pdf
- Duerden M, Avery T, Payne R Polypharmacy and medicines optimisation: Making it safe and sound. The King’s Fund.2013 Nov; [Cited 2016 Oct]. Available from http://www.kingsfund.org.uk/sites/files/kf/field/field_publication_file/polypharmacy-and-medicines-optimisation-kingsfund-nov13.pdf
- Jones E. Polypharmacy: Guidance for Prescribing in Frail Adults. NHS Wales. 2013 May;[Cited 2016 Oct] Available from http://www.wales.nhs.uk/sites3/Documents/814/PrescribingForFrailAdults-ABHBpracticalGuidance%5BMay2013%5D.pdf
- Nederlandse Vereniging voor Klinische Geriatrie. Richtlijn comprehensive geriatric assessment. Utrecht: Nederlandse Vereniging voor Klinische Geriatrie; 2013. [Cited 2016 Oct]. Available from http://www.nvkg.nl/uploads/OO/mD/OOmDnXm_K6ltEgqeOvCiiw/L-NVKG-A4-Publieksrichtlijn-CGA.pdf
- Socialstyrelsen. Läkemedelsgenomgångar för äldre ordinerade fem eller fler läkemedel. Stockholm: Socialstyrelsen; 2013. [Cited 2016 Oct]. Available from http://www.socialstyrelsen.se/publikationer2013/2013-3-18
- Stockholms läns landsting. Äldre och läkemedel, 2013. [Cited 2016Oct]. Available from http://www.janusinfo.se/imcms/images/laksak/Lakemedelsgenomgangar_riktlinjer_SLL_130301.pdf
- Nederlands Huisartsen Genootschap. Multidisciplinaire richtlijn Polyfarmacie bij ouderen 2012. Utrecht: Nederlands Huisartsen Genootschap; 2012. [Cited 2016 Oct]. Available from https://www.nhg.org/themas/publicaties/multidisciplinaire-richtlijn-polyfarmacie-bij-ouderen
- NHS Greater Glasgow & Clyde. Mindful prescribing strategy – polypharmacy. NHS. 2012 Dec, [Cited 2016 Oct]. Available from http://www.ggcprescribing.org.uk/media/uploads/prescribing_resources/mindful_prescribing_strategy_-_1212.pdf
- Melander A, Nilsson LG Olämpliga listan - Koll på läkemedel, 2011, [Cited 2016 Oct]. Available from http://www.kollpalakemedel.se/wp-content/uploads/2014/04/olaempliga_listan-20121219.pdf
- Verenso. Multidisciplinaire richtlijn diabetes bij kwetsbare ouderen. Utrecht: Verenso; 2011. [Cited 2016 Oct]. Available from http://www.verenso.nl/assets/Uploads/Downloads/Richtlijnen/VERRichtlijnDiabetesDeel12011web.pdf
- Socialstyrelsen. Indikatorer för god läkemedelsterapi hos äldre. Stockholm: Socialstyrelsen; 2010. [Cited 2016 Oct]. Available from http://www.socialstyrelsen.se/Lists/Artikelkatalog/Attachments/18085/2010-6-29.pdf
- Australian Government Department of Health. Guiding principles for medication management in residential aged care facilities, 2012, [Cited 2016 Oct]. Available from http://www.health.gov.au/internet/main/publishing.nsf/Content/nmp-pdf-resguide-cnt.htm
- Pharmaceutical Society of Australia. Guidelines for pharmacists providing Residential Medication Management Review (RMMR) and Quality Use of Medicines (QUM) services. [Cited 2016 Oct]. Available from https://www.psa.org.au/wpfb-file/rmmr-and-qum-services-pdf
- Royal Australian Collage of General Practitioners. Medical care of older persons in residential aged care facilities. Melbourne, Australia:Royal Australian Collage of General Practitioners. 2006.
- American Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity. Guiding principles for the care of older adults with multimorbidity: an approach for clinicians. J Am Geriatr Soc. 2012;60:E1–E25.
- Pellegrino AN, Martin MT, Tilton JJ, et al. Medication therapy management services: definitions and outcomes. Drugs. 2009;69:393–406.
- Best Practice Advocacy Centre.Polypharmacy in primary care: managing a clinical conundrum. Bpj. 2014;64:4–14. [Cited 2016 Oct]. http://www.bpac.org.nz/BPJ/2014/October/polypharmacy.aspx .
- Accounts Commission Scotland. Changing models of health and social care. Edinburgh: Audit Scotland; 2011.
- COSLA, Scottish Government and NHS Scotland. Reshaping care for older people: a programme for change 2011-2021. Edinburgh: Scottish Government; 2011. [Cited 2016 Oct]. Available from http://www.gov.scot/Topics/Health/Support-Social-Care/Support/Older-People/ReshapingCare
- The Scottish Government. The healthcare quality strategy for NHS Scotland. Edinburgh: The Scottish Government; 2010.
- Scottish Government Model of Care Polypharmacy Working Group. Polypharmacy Guidance. Edinburgh: Scottish Government; 2012.
- Information and Statistics Division, NHS Scotland. Scottish Patients at Risk of Readmission and Admission (SPARRA)—a report on the development of SPARRA. Edinburgh: NHS Scotland; 2011.
- Cook RJ, Sackett DL. The number needed to treat: a clinically useful measure of treatment effect. Bmj. 1995;310:452–454.
- O’Mahony D, O’Sullivan D, Byrne S, et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44:213–218.
- Rudolph JL, Angelini MC. McGlinchey RE The anticholinergic risk scale and anticholinergic adverse effects in older persons. Arch Intern Med. 2008;168:508–513.
- Carnahan RM, Perry PJ, Pollock BG, et al. The anticholinergic drug scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activity. J Clin Pharmacol. 2006;46:1481–1486.
- Scott A, Hilmer SN, Reeve E, et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Internal Medicine. 2015;175:827–834.
- British Medical Association, General Practitioners Committee. [Cited 2016 Oct]. Available from http://www.bma.org.uk/working-for-change/negotiating-for-the-profession/bma-general-practitioners-committee/gp-contract-negotiations/contract-agreement-scotland
- Stewart D, MacLure K, George J. Educating non-medical prescribers. Brit J Clin Pharm. 2012;74:662–667.
- The Scottish Government. Prescription for excellence: a vision and action plan for the right pharmaceutical care through integrated partnerships and innovation. Edinburgh: The Scottish Government; 2013.
- Thomas G. How to do your case study: a guide for students and researchers. London: Sage; 2012.
- Yin RK. Case study research: Design and methods. 4th ed. Thousand Oaks, CA: Sage; 2009.
- Murray CJ, Lopez AD. Measuring the global burden of disease. N Engl J Med. 2013;369:448–457.
- Bousquet J, Anto JM, Sterk PJ, et al. Systems medicine and integrated care to combat chronic noncommunicable diseases. Genome Med. 2011;3:43.
- Kotter JP. Leading change: why transformation efforts fail. IEEE Eng Man Rev. 1997;25:34–40.
- Heifetz RA, Linsky M. Leadership on the line. United States: Harvard Business Press; 2002.
- Heifetz RA, Grashow A, Linsky M. The practice of adaptive leadership: tools and tactics for changing your organization and the world. United States: Harvard Business Press; 2009.
- Mumford TV, Campion MA, Morgeson FP. The leadership skills strataplex: leadership skill requirements across organizational levels. The Leadership Quarterly. 2007;18:154–166.
- PRIMA-EDS. Polypharmacy in chronic diseases: reduction of inappropriate medication and adverse drug events in elderly populations by electronic decision support (PRIMA-eDS). [Cited 2016 Oct]. Available from http://www.prima-eds.eu/project/about-the-project/
- OPERAM. Optimising therapy to prevent avoidable hospital admissions in the multimorbid elderly. [Cited 2016 Oct]. Available from http://operam-2020.eu/
- SENATOR. Development and clinical trials of a new software engine for the assessment & optimization of drug and non-drug therapy in older persons. [Cited 2016 Oct]. Available from http://www.senator-project.eu/
- Healthcare Improvement Scotland. Scottish intercollegiate guidelines network. [cited May 2016]. Available from http://www.sign.ac.uk/